QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 2 February 2005
doi: 10.1242/dev.01640

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: dev.01640v1 132/5/1137    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, B. Articles by Baldwin, H. S. Search for Related Content PubMed PubMed Citation Articles by Zhou, B. Articles by Baldwin, H. S. Social Bookmarking                         What's this?

Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart

¹ Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
² Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

^* Author for correspondence (e-mail: bin.zhou{at}vanderbilt.edu)

Accepted 13 December 2004

Nfatc1 is an endocardial transcription factor required for development of cardiac valves. Herein, we describe identification and characterization of a tissue-specific enhancer in the first intron of murine Nfatc1 that activates a heterogenic promoter and directs gene expression in a subpopulation of endocardial cells of the developing heart: the pro-valve endocardial cells. This enhancer activity begins on embryonic day (E) 8.5 in endocardial cells at the ventricular end of the atrioventricular canal, intensifies and extends from E9.5 to E11.5 in endocardium along the atrioventricular canal and outflow tract. By E12.5, the enhancer activity is accentuated in endocardial cells of forming valves. Sequential deletion analysis identified that a 250 bp DNA fragment at the 3' end of the intron 1 is required for endocardial-specific activity. This region contains two short conserved sequences hosting a cluster of binding sites for transcription factors, including Nfat and Hox proteins. Electrophoresis mobility shift and chromatin immunoprecipitation assays demonstrated binding of Nfatc1 to the Nfat sites, and inactivation of Nfatc1 downregulated the enhancer activity in pro-valve endocardial cells. By contrast, mutation of the Hox site abolished its specificity, allowing gene expression in non pro-valve endocardium and extracardiac vasculature. Thus, autoregulation of Nfatc1 is required for maintaining high Nfatc1 expression in pro-valve endocardial cells, while suppression through the Hox site prevents its expression outside pro-valve endocardial cells during valve development. Our data demonstrate the first autonomous cell-specific enhancer for pro-valve endocardial cells and delineate a unique transcriptional mechanism that regulates endocardial Nfatc1 expression within developing cardiac valves.

Key words: Mouse, Heart, Endocardium, Nfatc1, Transcription, Enhancer

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. R. Torgerson, A. Genin, C. Chen, M. Zhang, B. Zhou, S. Anover-Sombke, M. B. Frank, I. Dozmorov, E. Ocheltree, P. Kulmala, et al. FOXP3 Inhibits Activation-Induced NFAT2 Expression in T Cells Thereby Limiting Effector Cytokine Expression J. Immunol., July 15, 2009; 183(2): 907 - 915. [Abstract] [Full Text] [PDF]

				M. Langworthy, B. Zhou, M. de Caestecker, G. Moeckel, and H. S. Baldwin NFATc1 Identifies a Population of Proximal Tubule Cell Progenitors J. Am. Soc. Nephrol., February 1, 2009; 20(2): 311 - 321. [Abstract] [Full Text] [PDF]

				P. Snider, R. B. Hinton, R. A. Moreno-Rodriguez, J. Wang, R. Rogers, A. Lindsley, F. Li, D. A. Ingram, D. Menick, L. Field, et al. Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart Circ. Res., April 11, 2008; 102(7): 752 - 760. [Abstract] [Full Text] [PDF]

				H. Wu, S.-c. Kao, T. Barrientos, S. H. Baldwin, E. N. Olson, G. R. Crabtree, B. Zhou, and C.-P. Chang Down Syndrome Critical Region-1 Is a Transcriptional Target of Nuclear Factor of Activated T Cells-c1 within the Endocardium during Heart Development J. Biol. Chem., October 19, 2007; 282(42): 30673 - 30679. [Abstract] [Full Text] [PDF]

				L. Song, W. Yan, X. Chen, C.-x. Deng, Q. Wang, and K. Jiao Myocardial Smad4 Is Essential for Cardiogenesis in Mouse Embryos Circ. Res., August 3, 2007; 101(3): 277 - 285. [Abstract] [Full Text] [PDF]

				M. Khandekar, W. Brandt, Y. Zhou, S. Dagenais, T. W. Glover, N. Suzuki, R. Shimizu, M. Yamamoto, K.-C. Lim, and J. D. Engel A Gata2 intronic enhancer confers its pan-endothelia-specific regulation Development, May 1, 2007; 134(9): 1703 - 1712. [Abstract] [Full Text] [PDF]

				M. Zubair, S. Ishihara, S. Oka, K. Okumura, and K.-i. Morohashi Two-Step Regulation of Ad4BP/SF-1 Gene Transcription during Fetal Adrenal Development: Initiation by a Hox-Pbx1-Prep1 Complex and Maintenance via Autoregulation by Ad4BP/SF-1. Mol. Cell. Biol., June 1, 2006; 26(11): 4111 - 4121. [Abstract] [Full Text] [PDF]

				D. Beis, T. Bartman, S.-W. Jin, I. C. Scott, L. A. D'Amico, E. A. Ober, H. Verkade, J. Frantsve, H. A. Field, A. Wehman, et al. Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development Development, September 15, 2005; 132(18): 4193 - 4204. [Abstract] [Full Text] [PDF]